Lv2
190 积分 2021-01-14 加入
Phase 1 Study of OPT-302 Inhibition of Vascular Endothelial Growth Factors C and D for Neovascular Age-Related Macular Degeneration
10天前
已完结
Vascular endothelial growth factor-C and its receptor-3 signaling in tumorigenesis
2个月前
已完结
Incidence Rate of Massive Submacular Hemorrhage and its Risk Factors in Polypoidal Choroidal Vasculopathy
2个月前
已完结
Review on classification of polypoidal choroidal vasculopathy
2个月前
已完结
Structural and Vascular Changes of the Choroid in Polypoidal Choroidal Vasculopathy after Intravitreal Anti-VEGF Therapy
2个月前
已完结
Review of Novel Third-Generation Tetracyclines: Eravacycline, Omadacycline, and Sarecycline
2个月前
已完结
Structural and Vascular Changes of the Choroid in Polypoidal Choroidal Vasculopathy after Intravitreal Anti-VEGF Therapy
3个月前
已关闭
Responsiveness of anti‐VEGF treatment for polypoidal choroidal vasculopathy based on aqueous humour proteomics: A preliminary study
3个月前
已完结
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
3个月前
已完结
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
